Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up

International Journal of Colorectal Disease

Volumn 19, Issue 2, 2004, Pages 157-164

  Ito, Katsuki ^a   Nakazato, Hiroaki ^b   Koike, Akihiko ^c   Takagi, Hiroshi ^a   Saji, Shigetoyo ^d   Baba, Shozo ^e   Mai, Masayoshi ^f   Sakamoto, Jun Ichi ^g   Ohashi, Yasuo ^h  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yokoyama Gastrointestinal Hospital   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

^g AICHI PREFECTURAL UNIVERSITY   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 Fluorouracil; Administration; Colon cancer; Immunochemotherapy; Intermittent; Polysaccharide K

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOQUONE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; KRESTIN; LEVAMISOLE; TEGAFUR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLON SURGERY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LIVER DYSFUNCTION; LONG TERM CARE; LYMPH NODE METASTASIS; MALE; MOUTH DISEASE; NAUSEA; PAIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SURGICAL TECHNIQUE; VOMITING;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTEOGLYCANS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1242353045     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-003-0532-x     Document Type: Article

References (31)

1. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare (ed) (2000) Vital statistics of Japan 1998, vol 1. Foundation of Statistics of Public Welfare Association, Tokyo, Japan
2. Kobayashi H, Matsunaga K, Oguchi Y (1995) Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev 4:275-281
3. Ikuzawa M, Matsunaga K, Nishiyama S, Nakajima S, Kobayashi Y, Andoh T, Kobayashi A, Ohhara M, Ohmura Y, Wada T (1988) Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). Int J Immunopharmacol 10:415-423
4. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343:1122-1126
5. Yasutomi M (ed) (1997) Japanese classification of colorectal carcinoma, 6th edn. Japanese Society for Cancer of the Colon and Rectum. Kanehara, Tokyo
6. Nakazato H, Ito K, Takagi H, Saji S, Koike A, Baba S, Mai M, Ohashi Y, Sakamoto J (1999) A randomized clinical trial on adjuvant immunochemotherapy with protein bound polysaccharide K (PSK) after curative resection of colon cancer. Presented at Am Soc Clin Oncol Annual Meeting, Atlanta, 15-18 May
7. Shah A, MacDonald W, Goldie J, Gudauskas G, Brisebois B (1985) 5-FU Infusion in advanced colorectal cancer. A comparison of three dose schedules. Cancer Treat Rep 69:739-742
8. Koike A, Kojima T, Kanemitsu T, Kato K, Naruse T, Suzumura K, Matsumoto K, Yamamoto S (1990) Treatment of advanced colorectal and gastric carcinomas with a 48-hour infusion of 5-fluorouracil. J Cancer Res Clin Oncol [Suppl]116:660
9. Koike A, Matsumoto K, Suzumura K, Saegusa J, Inamura Y, Kojima T, Kato K, Kanemitsu T, Naruse T, Yamamoto S (1990) Efficacy of a 48-hour infusion of 5-fluorouracil in patients with Stage IV gastric cancer after palliative gastrectomy (in Japanese with English abstract). Jpn J Cancer Chemother 17:1309-1314
10. Moertel CG, O'Fallon JR, Go VLW, O'Connel MJ, Thynne GS (1986) The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 58:603-610
11. Pocok SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115
12. Freedman LS (1982) Tables of the number of patients required in clinical trials using the log-rank test. Stat Med 1:121-129
13. Takashima S, Kinami Y, Miyazaki I (1988) Clinical effect of postoperative adjuvant immunochemotherapy with FT-207 suppository and PSK for colorectal cancer patients (in Japanese with English abstract). Jpn J Cancer Chemother 15:2229-2236
14. Colorectal Cancer Chemotherapy Study Group of Japan (1995) Five-year result of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 25:91-103
15. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H (1992) Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum 35:123-130
16. Mitomi T, Tsuchiya S, Iijima N, Aso K, Nishiyama K, Amano T, Takahashi T, Oka H, Murayama N, Oya K, Noto T, Ogawa N (1993) Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer-5 years follow-up after surgery (a final report) (in Japanese with English abstract). J Jpn Soc Cancer Ther 28:71-83
17. Moertel CG, Fleming TR, McDonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358
18. QUASAR Collaborative Group (2000) Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 355:1588-1596
19. Currie GA, Bagshawe KD (1970) Active immunotherapy with corynebacterium parvum and chemotherapy in murine fibrosarcomas. BMJ 1:541-544
20. Kondo T, Sakamoto J, Ichihashi H, Kamei H (1981) Effect of alternating administration of PS-K and carbazilquinone in tumor-bearing mice. Gann 72:293-299
21. Kondo T, Ichihashi H, Nakazato H, Ogawa N (1989) Result of adjuvant immunochemotherapy on 8-year survival using Krestin and Futraful for gastric cancer patients who underwent radical gastrectomy - a randomized controlled trial by cooperative study group (in Japanese with English abstract). Biotherapy 3:655-664
22. Kondo T, Sakamoto J, Nakazato H (1991) Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection. Biotherapy 3:287-295
23. Nakazato H, Koike A, Saji S (1990) Evaluation of PSK for gastric cancer patients who underwent radical gastrectomy (in Japanese with English abstract). Biotherapy 4:884-891
24. Ogoshi K, Miyaji M, Nakamura K, Kondoh Y, Makuuchi H, Tajima T (1998) Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants. Cancer Immunol Immunother 46:14-20
25. Kunieda K, Saji S, Tanemura H, Kato M, Sugiyama Y, Takao H, Umemoto T, Miya K, Azuma S, Furuta T (1992) Significance of preoperative serum IAP value for gastric cancer in terms of indication of postoperative BRM therapy (in Japanese with English abstract). J Jpn Soc Cancer Ther 27:1713-1721
26. Kidd PM (2000) The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4-27
27. Kato M, Hirose K, Hakozaki M, Ohno M, Saito Y, Izutani R, Noguchi J, Hori Y, Okumoto S, Kuroda D (1995) Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother 40:152-156
28. Noguchi K, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Tani M, Mizobata S, Hotta T, Arii K, Tamai M (1995) Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro. Anticancer Res 15:255-258
29. Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, Anai H, Maehara Y, Sugimachi K (1992) Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. Anticancer Res 12:645-648
30. Mizutani Y, Yoshida O (1991) Activation by the protein-bound polysaccharide PSK (Krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer. J Urol 145:1082-1087
31. Kariya Y, Inoue N, Kihara T, Okamoto N, Sugie K, Mori T, Uchida A (1992) Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2. Immunol Lett 31:241-246